Hematology Diagnostics Market Research Report – Forecast to 2027

Hematology Diagnostics Market Research Report, by Product Type (Hematology Analyzer, Flow Cytometer, Consumable), Tests (Hemoglobinopathy, Leukemia Phenotyping), End-User (Hospitals & Clinics, Diagnostic Laboratories) – Forecast Till 2027

ID: MRFR/LS/4801-HCR | | Region: Global | 100 pages

Hematology Diagnostics Market Scenario


Hematology Diagnostics Market Size is expected to reach USD 8.50 Billion, at a CAGR of 5%  forecast period 2020-2027

Hematology is the branch of science that deals with cause, prognosis, treatment, and prevention of blood disorders. The hematology diagnostics market is expected to witness tremendous growth owing to the rising prevalence of blood disorders and technological advancements. The Leukemia & Lymphoma Society (LLS) predicted 174,250 new cases of leukemia, lymphoma or myeloma in 2018 in the U.S. Other key factors like increase in the prevalence of genetic diseases, the rise in hematological testing, growing blood transfusions and donations and increasing adoption of automated hematology analyzers are contributing towards the growth of the hematology diagnostics market. According to the Centers for Disease Control and Prevention in 2017, approximately 70,000 to 100,000 Americans have sickle cell disease which is genetic blood disorder.


However, factors such as high cost of diagnostics, poor healthcare insurance coverage for diagnostic procedures and lack of awareness are expected to restrict the hematology diagnostics market growth during the forecast period.


Segmentation


The hematology diagnostics market is segmented on the basis of product type, tests, and end-user. The hematology diagnostics market, by product type categorized into hematology analyzers, flow cytometers, and consumables. Hematology analyzers category includes fully-automated hematology analyzers and semi-automated hematology analyzers. Consumables segment includes reagents, stains, controls & calibrators, and others. Tests category is further segmented into anemia, hemoglobinopathy, leukemia/lymphoma phenotyping, hematology pathophysiology, complete blood count (CBC) and others. On the basis of end-user, the hematology diagnostics market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, academic institutes and others.     


On the basis of region, the hematology diagnostics market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the U.S. and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.


Regional Market Summary


Hematology Diagnostics Market Share (%), by Region, 2017


Hematology Diagnostics Market Share


Sources:  Statista, the Centers for Disease Control and Prevention, the World Hematology Congress, Leukemia & Lymphoma Society (LLS)


The hematology diagnostics market is dominated by North America owing to the rising prevalence of blood diseases. According to Statista in 2016, 33% of all the Americans were diagnosed with hemophilia A were between 19-44 years of age. The presence of major market players such as Abbott Laboratories Danaher, Bio-Rad Laboratories, and others within the region also influences the market growth. Other factors like increasing healthcare expenditure, technological advancements within the population drive the hematology diagnostics market growth in this region.


It is estimated that Europe stood second in the hematology diagnostics market owing to increasing hematology research within this region. The 16th World Hematology Congress will be conducted in March 2019 in London, UK to discuss the diagnosis and treatment of hematology, blood disorders, hematologic oncology, hematologic disorders, and immunohematology. Thus, increasing hematology research and government initiatives within this region influences the growth of hematology diagnostics market in this region.


Asia-Pacific was projected to be the fastest growing region for the hematology diagnostics market in 2017. The hematology diagnostics market is expected to witness growth owing to the rising prevalence of blood disorders and genetic diseases. The South Asians are more vulnerable to genetic disorders due to consanguineous marriages or marrying within the same ethnicity, community, caste, etc. 


The Middle East and Africa holds the least share in the hematology diagnostics market due to the presence of stringent government policies and poor economies. However, the market is expected to witness growth due to high investments by the private market players in the Middle East. Also, the growing prevalence of genetic blood disorders and rising government initiatives to improve the healthcare sector within the region contribute to hematology diagnostics market growth.


Market Segmentation and Key Market Players


Hematology Diagnostics Market, by Product Type



  • Hematology Analyzers

    • Fully-automated Hematology Analyzers

    • Semi-automated Hematology Analyzers



  • Flow Cytometers

  • Consumables

    • Reagents

    • Stains

    • Controls & Calibrators



  • Others


Hematology Diagnostics Market, by Tests



  • Anemia

  • Hemoglobinopathy

  • Leukemia/Lymphoma Phenotyping

  • Hematology pathophysiology

  • Complete blood count (CBC)

  • Others


Hematology Diagnostics Market, by End-User



  • Hospitals & Clinics

  • Ambulatory Surgical Centers

  • Diagnostic Laboratories

  • Academic Institutes

  • Others


Hematology Diagnostics Market, by Region



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa


Hematology Diagnostics Market, by Key Players



  • Sysmex (Japan)

  • Danaher (US)

  • Nihon Kohden (Japan)

  • Siemens (Germany)

  • Abbott Laboratories (US)

  • Boule Diagnostics (Sweden)

  • HORIBA (Japan)

  • Bio-Rad Laboratories (US)

  • BioSystems (Spain)

  • Diatron (Hungary)

  • Drew Scientific (US)

  • EKF Diagnostics (UK)

  • Mindray (China)

  • Ortho Clinical Diagnostics (US)

  • Roche (Switzerland) 


Intended Audience



  • Pharmaceutical companies

  • Biotechnological institutes

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: USD 8.50 Billion
  CAGR   5% (2020-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type, Tests, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Sysmex (Japan), Danaher (US), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), Roche (Switzerland)
  Key Market Opportunities

  • Rising prevalence of blood disorders
  • Technological advancements

    		•
      Key Market Drivers

  • Increase in the prevalence of genetic diseases
  • The rise in hematological testing
  • Growing blood transfusions and donations
  • Increasing adoption of automated hematology analyzers

    		•


    Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Hematology Diagnostics Market is to reach at USD 8.50 Billion by 2027

    Hematology Diagnostics Market is expected to register a CAGR of 5% during the forecast period of 2020 to 2027

    key factors like increase in the prevalence of genetic diseases, the rise in hematological testing, growing blood transfusions and donations and increasing adoption of automated hematology analyzers are contributing towards the growth of the market.

    The hematology diagnostics market is dominated by North America owing to the rising prevalence of blood diseases.

    The central contenders in the hematology diagnostics market globally are Ortho Clinical Diagnostics (US), Danaher (US), Siemens (Germany), Boule Diagnostics (Sweden), HORIBA (Japan), Abbott Laboratories (US), EKF Diagnostics (UK), Bio-Rad Laboratories (US), BioSystems (Spain), Sysmex (Japan), Diatron (Hungary), Nihon Kohden (Japan), Drew Scientific (US), Mindray (China), and Roche (Switzerland), and other.

    TABLE OF CONTENT


    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Hematology Diagnostics Market, by Product Type

    6.1 Introduction

    6.2 Hematology Analyzers

    6.2.1 Fully-automated Hematology Analyzers

    6.2.2 Semi-automated Hematology Analyzers

    6.3 Flow Cytometers

    6.4 Consumables

    6.4.1 Reagents

    6.4.2 Stains

    6.4.3 Controls & Calibrators

    6.5 Others

    Chapter 7. Global Hematology Diagnostics Market, by Tests

    7.1 Introduction

    7.2 Anemia

    7.3 Hemoglobinopathy

    7.4 Leukemia/Lymphoma Phenotyping

    7.5 Hematology pathophysiology

    7.6 Complete Blood Count (CBC)

    7.7 Others

    Chapter 8. Global Hematology Diagnostics Market, by End-User

    8.1 Introduction

    8.2 Hospitals & Clinics

    8.3 Ambulatory Surgical Centers

    8.4 Diagnostic Laboratories

    8.5 Academic Institutes

    8.6 Others

    Chapter 9. Global Hematology Diagnostics Market, by Region

    9.1 Introduction

    9.2 America

    9.2.1 North America

    9.2.1.1 US

    9.2.1.2 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.4 Spain

    9.3.1.5 UK

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia-Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 Republic of Korea

    9.4.6 Rest of Asia-Pacific

    9.5 Middle East & Africa

    9.5.1 United Arab Emirates

    9.5.2 Saudi Arabia

    9.5.3 Oman

    9.5.4 Kuwait

    9.5.5 Qatar

    9.5.6 Rest of the Middle East & Africa

    Chapter 10. Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    10.3.1 Key Developments

    Chapter 11 Company Profiles

    11.1 Sysmex

    11.1.1 Company Overview

    11.1.2 Type Overview

    11.1.3 Financials

    11.2.4 Key Developments

    11.1.5 SWOT Analysis

    11.2 Danaher

    11.2.1 Company Overview

    11.2.2 Type Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 Nihon Kohden

    11.3.1 Company Overview

    11.3.2 Type Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Siemens

    11.4.1 Company Overview

    11.4.2 Type/Business Segment Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 Abbott Laboratories

    11.5.1 Company Overview

    11.5.2 Type Overview

    11.5.3 Financial overview

    11.5.4 Key Developments

    11.5.5 SWOT Analysis

    11.6 Boule Diagnostics

    11.6.1 Company Overview

    11.6.2 Type Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.6.5 SWOT Analysis

    11.7 HORIBA

    11.7.1 Overview

    11.7.2 Type Overview

    11.7.3 Financials

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 Bio-Rad Laboratories

    11.8.1 Overview

    11.8.2 Type Overview

    11.8.3 Financials

    11.8.4 Key Developments

    11.8.5 SWOT Analysis

    11.9 BioSystems

    11.9.1 Overview

    11.9.2 Type Overview

    11.9.3 Financials

    11.9.4 Key Developments

    11.9.5 SWOT Analysis

    11.10 Diatron

    11.10.1 Overview

    11.10.2 Type Overview

    11.10.3 Financials

    11.10.4 Key Developments

    11.10.5 SWOT Analysis

    11.11 EKF Diagnostics

    11.11.1 Overview

    11.11.2 Type Overview

    11.11.3 Financials

    11.11.4 Key Developments

    11.11.5 SWOT Analysis

    11.12 Drew Scientific

    11.12.1 Overview

    11.12.2 Type Overview

    11.12.3 Financials

    11.12.4 Key Developments

    11.12.5 SWOT Analysis

    11.13 Mindray

    11.13.1 Overview

    11.13.2 Type Overview

    11.13.3 Financials

    11.13.4 Key Developments

    11.13.5 SWOT Analysis

    11.14 Ortho Clinical Diagnostics

    11.13.1 Overview

    11.13.2 Type Overview

    11.13.3 Financials

    11.13.4 Key Developments

    11.13.5 SWOT Analysis

    11.15 Roche

    11.13.1 Overview

    11.13.2 Type Overview

    11.13.3 Financials

    11.13.4 Key Developments

    11.13.5 SWOT Analysis
    11.16 Others

    Chapter 12 Appendix


    LIST OF TABLES


    Table 1 Hematology Diagnostics Market Industry Synopsis, 2020-2027

    Table 2 Global Hematology Diagnostics Market Estimates & Forecast, 2020-2027, (USD Million)

    Table 3 Global Hematology Diagnostics Market, by Region, 2020-2027, (USD Million)

    Table 4 Global Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)

    Table 5 Global Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)

    Table 6 Global Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million

    Table 7 North America Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)

    Table 8 North America Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)

    Table 9 North America Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)

    Table 10 US Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)

    Table 11 US Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)

    Table 12 US Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)

    Table 13 Canada Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)

    Table 14 Canada Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)

    Table 15 Canada Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)

    Table 16 South America Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)

    Table 17 South America Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)

    Table 18 South America Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)

    Table 19 Europe Hematology Diagnostics Market, Product Type, 2020-2027, (USD Million)

    Table 20 Europe Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)

    Table 21 Europe Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)

    Table 22 Western Europe Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)

    Table 23 Western Europe Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)

    Table 24 Western Europe Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)

    Table 25 Eastern Europe Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)

    Table26 Eastern Europe Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)

    Table 27 Eastern Europe Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)

    Table 28 Asia-Pacific Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)

    Table 29 Asia-Pacific Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)

    Table 30 Asia-Pacific Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)

    Table 31 The Middle East & Africa Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)

    Table 32 The Middle East & Africa Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)

    Table 33 The Middle East & Africa Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)
    LIST OF FIGURES


    Figure 1 Research Process

    Figure 2 Segmentation for Global Hematology Diagnostics Market

    Figure 3 Market Dynamics for Global Hematology Diagnostics Market

    Figure 4 Global Hematology Diagnostics Market Share, by Product Type 2020

    Figure 5 Global Hematology Diagnostics Market Share, by Tests 2020

    Figure 6 Global Hematology Diagnostics Market Share, by End-User, 2020

    Figure 7 Global Hematology Diagnostics Market Share, by Region, 2020

    Figure 8 North America Hematology Diagnostics Market Share, by Country, 2020

    Figure 9 Europe Hematology Diagnostics Market Share, by Country, 2020

    Figure 10 Asia-Pacific Hematology Diagnostics Market Share, by Country, 2020

    Figure 11 Middle East & Africa Hematology Diagnostics Market Share, by Country, 2020

    Figure 12 Global Hematology Diagnostics Market: Company Share Analysis, 2020 (%)

    Figure 13 SYSMEX: Key Financials

    Figure 14 SYSMEX: Segmental Revenue

    Figure 15 SYSMEX: Geographical Revenue

    Figure 16 Danaher: Key Financials

    Figure 17 Danaher: Segmental Revenue

    Figure 18 Danaher: Geographical Revenue

    Figure 19 Nihon Kohden: Key Financials

    Figure 20 Nihon Kohden: Segmental Revenue

    Figure 21 Nihon Kohden: Geographical Revenue

    Figure 22 Siemens: Key Financials

    Figure 23 Siemens: Segmental Revenue

    Figure 24 Siemens: Geographical Revenue

    Figure 25 Abbott Laboratories: Key Financials

    Figure 26 Abbott Laboratories: Segmental Revenue

    Figure 27 Abbott Laboratories: Geographical Revenue

    Figure 28 Boule Diagnostics Laboratories: Key Financials

    Figure 29 Boule Diagnostics Laboratories: Segmental Revenue

    Figure 30 Boule Diagnostics Laboratories: Geographical Revenue

    Figure 31 HORIBA: Key Financials

    Figure 32 HORIBA: Segmental Revenue

    Figure 33 HORIBA: Geographical Revenue

    Figure 34 Bio-Rad Laboratories: Key Financials

    Figure 35 Bio-Rad Laboratories: Segmental Revenue

    Figure 36 Bio-Rad Laboratories: Geographical Revenue

    Figure 37 BioSystems: Key Financials

    Figure 38 BioSystems: Segmental Revenue

    Figure 39 BioSystems: Geographical Revenue

    Figure 40 Diatron: Key Financials

    Figure 41 Diatron: Segmental Revenue

    Figure 42 Diatron: Geographical Revenue

    Figure 46 Drew Scientific: Key Financials

    Figure 47 Drew Scientific: Segmental Revenue

    Figure 48 Drew Scientific: Geographical Revenue

    Figure 49 Mindray: Key Financials

    Figure 50 Mindray: Segmental Revenue

    Figure 51 Mindray: Geographical Revenue

    Figure 52 Ortho Clinical Diagnostics: Key Financials

    Figure 53 Ortho Clinical Diagnostics: Segmental Revenue

    Figure 54 Ortho Clinical Diagnostics: Geographical Revenue

    Figure 55 Roche: Key Financials

    Figure 56 Roche: Segmental Revenue

    Figure 57 Roche: Geographical Revenue